Several locations have started high volume screening with Hologic 3D
Mammography™ in Europe. A large scale adoption is ongoing in
the USA with some locations past their third screening round with
Hologic 3D Mammography. Results from the use of this technology
in screening are concordant and very positive around an increase
in invasive cancer detection and a reduction in recall rates.
Practical advices regarding Hologic 3D Mammography™
implementation are discussed in many forums and so are the
impact on screening assessment. Leaders using Hologic 3D
Mammography™ in screening will share their experiences from
implementation and give their view on further positive evolutions
in the future.
Friday, March 4th
14.00 - 15.00
Austria Center - Hall C
Moderator of Session:
Prof. emer Per Skaane